CD31 (PECAM-1) (D8V9E) Rabbit Monoclonal Antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0456379
- Awardee
- CELL SIGNALING TECHNOLOGY INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $380.70
About this award
Cell Signaling Technology Inc. was awarded contract A207_PO-0456379 by the University of Virginia on July 9, 2026, for a cumulative contract value of $380. The prime contractor will deliver CD31 (Platelet Endothelial Cell Adhesion Molecule-1) (D8V9E) Rabbit Monoclonal Antibody to Anthony Christopher Bruce at the University of Virginia location in Virginia. The line item consists of one unit priced at $380.70.
The contract encompasses the provision of a single monoclonal antibody reagent used in biological research and diagnostics. No specific period of performance, county designation, or annual value information is provided in the contract documentation. The University of Virginia serves as the contracting organization for this procurement.
Line items
| Item | Total |
|---|---|
| CD31 (PECAM-1) (D8V9E) Rabbit Monoclonal Antibody | $380.70 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0456379?
Contract A207_PO-0456379 was awarded to CELL SIGNALING TECHNOLOGY INC. by University of Virginia on July 9, 2026.
How much is contract A207_PO-0456379 worth?
Its cumulative value is $380.70.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award